CLZNF:OTC-Clariant AG (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 20.10

Change

0.00 (0.00)%

Market Cap

USD 7.01B

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Clariant AG, together with its subsidiaries, develops, manufactures, distributes, and sells specialty chemicals worldwide. It operates in four segments: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. The company offers flame retardants, performance additives, and advanced surface solutions for use in plastics, coatings, inks, and other applications; and catalysts for the petrochemical and refining, synthesis gas, chemical, emissions control, specialty zeolites and zeolite-based, and custom catalyst markets. It also provides bentonite based specialty products for the oil purification, foundry additive, desiccant, oxygen absorber, humidity, sediment management, civil engineering, waste water treatment, clay specialties, paper and detergent additive, PVC stabilizer, BTX-catalyst, and kerosene and jet fuel purification industries. In addition, the company offers industrial and consumer specialty chemicals and application solutions for the automotive brake fluid and coolant, aircraft anti-itching and deicing fluid, construction chemical, agrochemical, gas treatment, heat transfer fluid, home care, industrial and institutional cleaning, industrial lubricant additive, special solvent, paint and coating, and personal care and cosmetic ingredient markets. Further, it provides masterbatches for the agriculture, consumer goods, healthcare packaging, healthcare polymer solutions, packaging, fibers, and transportation markets; oil, mining, and refinery services to the oil and mining industries; and organic pigments, pigment preparations, and dyes for coatings, printing, plastics, consumer products, non-impact printing, and other special applications. Additionally, the company offers biotech and bio-based chemicals; electronic materials; food ingredients; VitiSpheres encapsulated active ingredients; and 3D printing filaments. Clariant AG was founded in 1886 and is headquartered in Muttenz, Switzerland.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-02-26 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SXYAY Sika AG

-0.43 (-1.59%)

USD38.01B 59.73 33.55
SKFOF Sika AG

-8.00 (-2.92%)

USD36.39B 60.66 32.37
GVDBF Givaudan SA

-169.08 (-4.22%)

USD35.47B 52.22 30.49
GVDNY Givaudan SA

-0.58 (-0.76%)

USD35.30B 50.02 31.39
KDSKF Koninklijke DSM N.V

-2.61 (-1.54%)

USD29.07B 25.93 38.28
RDSMY Koninklijke DSM N.V

-0.71 (-1.69%)

USD29.07B 25.78 38.28
NPCPF Nippon Paint Holdings Co., Ltd

N/A

USD25.04B 95.63 0.28
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD21.15B 42.35 41.44
AKZOF Akzo Nobel N.V

+0.78 (+0.76%)

USD19.88B 25.37 16.55
AKZOY Akzo Nobel N.V

-0.17 (-0.47%)

USD19.39B 31.18 16.55

ETFs Containing CLZNF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -7.59% 13% F 25% F
Dividend Return 14.58% 95% A 94% A
Total Return 7.00% 19% F 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -8.03% 19% F 22% F
Dividend Return 3.87% 94% A 62% D-
Total Return -4.16% 27% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 13.31% 94% A 86% B
Risk Adjusted Return -31.27% 22% F 22% F
Market Capitalization 7.01B 70% C- 86% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 38.63 28% F 19% F
Price/Book Ratio 2.39 52% F 42% F
Price / Cash Flow Ratio 19.01 23% F 11% F
EV/EBITDA 13.22 43% F 28% F
Management Effectiveness  
Return on Equity 4.59% 44% F 57% F
Return on Invested Capital -4.19% 23% F 33% F
Return on Assets 3.60% 61% D- 78% C+
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.25 26% F 35% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.